Seas the Day: Innovation Behind the Gear - Velocity
News, Team news
05/06/2025
As Miriam Payne and Jess Rowe embark on their 8,000-mile Pacific Ocean odyssey, the cutting-edge equipment they rely on is vital for their safety, efficiency, and communication. As proud sponsors, we're thrilled to follow their incredible journey. Much of this indispensable gear is, or was, protected by intellectual property (IP) rights. In this first article of our series, we'll delve into key pieces of equipment, starting with the most important: the boat, Velocity.
Read more
EUIPO Mediation: Efficient Dispute Resolution for EUTMs & EU Designs
European, News
05/06/2025
As of June 2, 2025, the European Union Intellectual Property Office (EUIPO) has expanded its mediation services to cover all inter partes proceedings. This means if you're involved in EU trade mark (EUTM) opposition or cancellation proceedings, or registered EU design (EUD) invalidity proceedings (at both first and second instances), you can now opt for mediation to resolve your dispute amicably and efficiently.
Read more
Secerna LLP Celebrates Fifth Consecutive Recognition in Prestigious IAM Patent 1000 Rankings
Industry news, News
30/05/2025
Secerna LLP is delighted to announce its continued recognition in the highly respected IAM Patent 1000 directory for an impressive fifth year in a row. This sustained acknowledgement solidifies Secerna’s standing as a leading firm in patent prosecution, a testament to its unwavering commitment to excellence and the exceptional expertise of its partners and dedicated team.
Read more
A to Z: Drugs in Highlight: Z is for ZELBORAF®
News, A to Z Feature
29/05/2025
Our A to Z series draws to a close. In this final instalment we highlight ZELBORAF® (from Roche and Daiichi Sankyo) which is used to treat patients with melanoma (a type of skin cancer).
Read more
A to Z: Drugs in Highlight: Y is for YONDELIS®
News, A to Z Feature
22/05/2025
Our A to Z series highlights YONDELIS® (originating from Pharma Mar) is used for treating advanced soft-tissue sarcoma and ovarian cancer.
Read more
Secerna to attend BioFocus Conference 2025 in Newcastle
Events, News
22/05/2025
Meet Secerna's European Patent Attorney, John Harbottle, and Part Qualified Patent Attorney, Niamh Crabtree, who will be attending the 2025 BioFocus Conference on Wednesday 11th June at The Catalyst, Newcastle Helix, Newcastle.
Read more